Back to Archived Journals » Comparative Effectiveness Research » Volume 7

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Total article views   HTML views PDF downloads Totals
11,204 Dovepress* 11,204+ 826 12,030
Totals 11,204 826 12,030
*Since 23 January 2017

View citations on Google Scholar